Effects of NK-104, a new hydroxymethylglutaryl-coenzyme reductase inhibitor, on low-density lipoprotein cholesterol in heterozygous familial hypercholesterolemia
- 15 January 2000
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 85 (2) , 178-183
- https://doi.org/10.1016/s0002-9149(99)00656-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effects of atorvastatin on serum lipids of patients with familial hypercholesterolaemiaJournal of Internal Medicine, 1998
- Effect of itraconazole on the pharmacokinetics of atorvastatin*Clinical Pharmacology & Therapeutics, 1998
- Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase InhibitorsClinical Pharmacokinetics, 1997
- Efficacy and Safety of a New HMG-CoA Reductase Inhibitor, Atorvastatin, in Patients With HypertriglyceridemiaJAMA, 1996
- Prevention of coronary heart disease in clinical practice: recommendations of the task force of the European Society of cardiology, European atherosclerosis Society and European society of HypertensionAtherosclerosis, 1994
- National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).Circulation, 1994
- Serum apolipoproteins in heterozygous familial hypercholesterolemiaClinica Chimica Acta; International Journal of Clinical Chemistry, 1992
- Effects of CS-514 on serum lipoprotein lipid and apolipoprotein levels in patients with familial hypercholesterolemiaMetabolism, 1987
- Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.Circulation, 1981
- Serum lipid and lipoprotein levels in Japanese patients with familial hypercholesterolemiaAtherosclerosis, 1979